Research programme: adipose-derived stem cell therapeutics - American CryoStem Corporation/Rutgers

Drug Profile

Research programme: adipose-derived stem cell therapeutics - American CryoStem Corporation/Rutgers

Alternative Names: ADSC therapeutics

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator American CryoStem Corporation; Rutgers
  • Class Cytokines; Extracellular matrix proteins; Growth factors; Stem cell factors; Stem cell therapies; Tissue extracts
  • Mechanism of Action Cell replacements; Cytokine stimulants; Growth stimulants; Tissue replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Chronic wounds; Skin ulcer

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for research development in Chronic-wounds in USA (Parenteral)
  • 16 Jul 2016 No recent reports of development identified for research development in Skin-ulcer in USA (Parenteral)
  • 14 May 2013 American CryoStem and Rutgers, the State University of New Jersey, sign a Material Transfer Agreement to research, develop and commercialise adipose-derived stem cells (ADSCs) in the US for Chronic wounds and Skin ulcers
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top